首页> 外文期刊>Pharmacognosy Research >Protective effects of goldenseal (Hydrastis canadensis L.) on acetaminophen-induced hepatotoxicity through inhibition of CYP2E1 in rats
【24h】

Protective effects of goldenseal (Hydrastis canadensis L.) on acetaminophen-induced hepatotoxicity through inhibition of CYP2E1 in rats

机译:毛eal(Hydrastis canadensis L.)通过抑制CYP2E1对大鼠对乙酰氨基酚诱导的肝毒性的保护作用

获取原文
           

摘要

Background:Goldenseal (Hydrastis canadensis L.) inhibits various cytochrome P450 (CYP) isoforms such as CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A in vitro. High doses of acetaminophen (APAP) generate the highly reactive intermediate, N-acetyl-p-benzoquinone imine (NAPQI), catalyzed mainly by CYP2E1. The aim of this study was to investigate the hepatoprotective effects of orally administrated goldenseal against APAP-induced acute liver failure (ALF) via inhibition of CYP2E1.Materials and Methods:Male Wistar rats were treated orally with goldenseal (300 and 1000 mg/kg) 2, 18, and 26 h before and 6 h after oral APAP (400 mg/kg) administration. Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities as well as serum APAP concentration were evaluated.Results:Goldenseal extract inhibited CYP1A2, CYP2D6, CYP2E1, and CYP3A activity, and the inhibitory effect on CYP2E1 was the strongest (IC50 4.32 μg/mL). Treatment with goldenseal (300 mg/kg) significantly attenuated the APAP-induced increase in serum AST and ALT, and the hepatoprotective effect of goldenseal was stronger than that of silymarin (200 mg/kg). Moreover, serum APAP concentration was increased by goldenseal treatment, presumably as a result of the inhibitory effect of goldenseal on the metabolism of APAP to NAPQI.Conclusion:These results suggest that goldenseal ameliorates APAP-induced ALF and that this protection can likely be attributed to the inhibition of CYP2E1 activity, which generates the highly reactive intermediate of APAP.
机译:背景:Goldenseal(Hydrastis canadensis L.)在体外抑制多种细胞色素P450(CYP)亚型,例如CYP2C9,CYP2C19,CYP2D6,CYP2E1和CYP3A。高剂量的对乙酰氨基酚(APAP)产生高反应性的中间体N-乙酰基-对-苯醌亚胺(NAPQI),主要由CYP2E1催化。这项研究的目的是研究口服金枪鱼通过抑制CYP2E1对APAP诱导的急性肝衰竭(ALF)的保肝作用。材料和方法:雄性Wistar大鼠口服金枪鱼(300和1000 mg / kg)口服APAP(400 mg / kg)之前,之后2小时,18小时和26小时。测定血清天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)的活性以及血清APAP的浓度。 / mL)。用金毛(300 mg / kg)处理可显着减弱APAP诱导的血清AST和ALT升高,并且金毛的肝保护作用比水飞蓟素(200 mg / kg)强。此外,白毛treatment处理可能会导致血清APAP浓度升高,这可能是由于白毛on对APAP代谢成NAPQI的抑制作用。结论:这些结果表明,白毛eal改善了APAP诱导的ALF,这种保护作用可能归因于抑制CYP2E1活性,从而产生APAP的高反应性中间体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号